FLT-PET And FDG-PET/CT For The Detection Of Relapse Following Definitive Radiotherapy In Non-small Cell Lung Cancer. Preliminary Results

被引：0
|
作者：
Christensen, T. [1 ,2 ]
Langer, S. W. [3 ]
Larsen, K. R. [4 ]
Persson, G. F. [5 ]
Amtoft, A. G. [1 ]
Johannesen, H. H. [1 ]
Keller, S. H. [1 ]
Kjaer, A. [1 ,2 ]
Fischer, B. M. B. [1 ]
机构：
[1] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark
[2] Univ Copenhagen, Cluster Mol Imaging, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Oncol, Rigshosp, Copenhagen, Denmark
[4] Univ Copenhagen, Bispebjerg Hosp, Dept Pulm Med, Copenhagen, Denmark
[5] Univ Copenhagen, Herlev Hosp, Dept Oncol, Copenhagen, Denmark
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-173
引用
收藏
页码：S74 / S75
页数：2
相关论文
共 50 条
  • [41] [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer
    Been, Lukas B.
    Hoekstra, Harald J.
    Suurmeijer, Albert J. H.
    Jager, Pieter L.
    van der Laan, Bernard F. A. M.
    Elsinga, Philip H.
    ORAL ONCOLOGY, 2009, 45 (12) : E211 - E215
  • [42] FDG-PET/CT in pulmonary and cardiac Langerhans' cell histiocytosis and metastatic non-small cell lung cancer
    Schreiber, Jens
    Waldburg, Nadine
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (08) : 1173 - 1174
  • [43] Assessing the Feasibility of FLT-PET for Evaluation of Non-Small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiotherapy (SBRT)
    Raziee, H.
    Hope, A.
    Bezjak, A.
    Sun, A.
    Cho, J.
    Bissonnette, J.
    Vines, D.
    Driscoll, B.
    Giuliani, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2041 - S2041
  • [44] Impact of 18F FDG PET/CT on staging of non-small cell lung cancer.
    Promteangtrong, Chetsadaporn
    Kunawudhi, Anchisa
    Phadungrerk, Rossarin
    Lamsa-art, Chanidapa
    Chotipanich, Chanisa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?
    Clarke, Katy
    Taremi, Mojgan
    Dahele, Max
    Freeman, Marc
    Fung, Sharon
    Franks, Kevin
    Bezjak, Andrea
    Brade, Anthony
    Cho, John
    Hope, Andrew
    Sun, Alexander
    RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) : 62 - 66
  • [46] Stereotactic Body Radiotherapy (SBRT) for Non-small Cell Lung Cancer (NSCLC) -is FDG-PET a Predictor of Outcome?
    Clarke, K. L.
    Taremi, M.
    Freeman, M.
    Fung, S.
    Dahele, M.
    Bezjak, A.
    Brade, A.
    Cho, J.
    Hope, A.
    Sun, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S499 - S500
  • [47] Clinical utilities of FDG-PET/CT in small cell lung cancer
    Ishimori, Takayoshi
    Watanabe, Yuji
    Sakata, Chie
    Ichihashi, Shigeo
    Nakashita, Satoru
    Maki, Daisuke
    Yabuta, Minoru
    Arimoto, Maya
    Ikeda, Itaru
    Dodo, Yoshihiro
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [48] Evaluation of Cost-effectiveness of FDG-PET in Non-Small Cell Lung Cancer
    Hoekstra, Otto S.
    van Tinteren, Harm
    Smit, Egbert F.
    PET CLINICS, 2006, 1 (04) : 329 - +
  • [49] THE PROGNOSTIC SIGNIFICANCE OF FDG-PET IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Bae, S. H.
    Ryoo, H. M.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S64 - S64
  • [50] Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer
    Abe, Koichiro
    Baba, Shingo
    Kaneko, Koichiro
    Isoda, Takuro
    Yabuuchi, Hidetake
    Sasaki, Masayuki
    Sakai, Shuji
    Yoshino, Ichiro
    Honda, Hiroshi
    CLINICAL IMAGING, 2009, 33 (02) : 90 - 95
12345